Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma. | Cancer Med | 2023 | 36708047 | PubTator, text mining | PubMed |
| Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma. | Breast Cancer Res | 2023 | 36707876 | PubTator, text mining | PubMed |
| Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma. | Cancer Discov | 2023 | 36700848 | PubTator, text mining | PubMed |
| Towards a structurally resolved human protein interaction network. | Nat Struct Mol Biol | 2023 | 36690744 | PubTator, text mining | PubMed |
| Pathogenicity of PKCγ Genetic Variants-Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer. | Genes (Basel) | 2023 | 36672978 | PubTator, text mining | PubMed |
| Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK. | J Oncol | 2023 | 36644234 | PubTator, text mining | PubMed |
| TMT-based quantitative proteomic analysis reveals the underlying mechanisms of glycidyl methacrylate-induced 16HBE cell malignant transformation. | Toxicology | 2023 | 36641056 | PubTator, text mining | PubMed |
| Exploring pradimicin-IRD antineoplastic mechanisms and related DNA repair pathways. | Chem Biol Interact | 2023 | 36634904 | PubTator, text mining | PubMed |
| A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma. | J Transl Med | 2023 | 36624463 | PubTator, text mining | PubMed |
| Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. | Nat Med | 2023 | 36624313 | PubTator, text mining | PubMed |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. | Ann Hematol | 2023 | 36622392 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
| Return of individual genomic research results within the PRAEGNANT multicenter registry study. | Breast Cancer Res Treat | 2023 | 36409394 | PubTator, text mining | PubMed |
| Progress in precision therapy in pediatric oncology. | Curr Opin Pediatr | 2023 | 36377257 | PubTator, text mining | PubMed |
| Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies. | Turk Patoloji Derg | 2023 | 36367123 | PubTator, text mining | PubMed |
| Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. | J Natl Cancer Inst | 2023 | 36315097 | PubTator, text mining | PubMed |
| Identification of risk genes in Chinese nonobstructive azoospermia patients based on whole-exome sequencing. | Asian J Androl | 2023 | 36259570 | PubTator, text mining | PubMed |
| DNA damage accumulation and repair defects in FLT3-ITD acute myeloid leukemia: Implications for clonal evolution and disease progression. | Hematol Oncol | 2023 | 36131612 | PubTator, text mining | PubMed |
| The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis. | Cancer Med | 2023 | 35691022 | PubTator, text mining | PubMed |
| The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta-analysis. | Cancer Med | 2023 | 35637613 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=12